Design Therapeutics Correlations

DSGN Stock

USD 4.08 0.11 2.77%

The current 90-days correlation between Design Therapeutics and Monte Rosa Therapeutics is 0.28 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Design Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Design Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Design Therapeutics Correlation With Market

Average diversification

The correlation between Design Therapeutics and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Design Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.

Moving together with Design Stock

0.63	MRK	Merck Company	Pair Corr
0.71	ORGN	Origin Materials	Pair Corr

Moving against Design Stock

0.65	DRTSW	Alpha Tau Medical	Pair Corr
0.47	GILD	Gilead Sciences	Pair Corr
0.46	ABBV	AbbVie Inc	Pair Corr
0.71	TD	Toronto Dominion Bank	Pair Corr
0.66	OKTA	Okta Inc	Pair Corr
0.65	META	Meta Platforms Aggressive Push	Pair Corr
0.61	GS	Goldman Sachs Group	Pair Corr
0.59	WMT	Walmart Earnings Call This Week	Pair Corr
0.58	PLTR	Palantir Technologies Aggressive Push	Pair Corr
0.45	DUOT	Duos Technologies	Pair Corr
0.43	MMSI	Merit Medical Systems	Pair Corr
0.42	COST	Costco Wholesale Corp	Pair Corr
0.38	ANET	Arista Networks Earnings Call This Week	Pair Corr

Related Correlations Analysis

	GLUE	HOWL	IKNA	STOK	ACHL	NLTX	MGTA	GRPH	ALXO	AADI
GLUE		0.89	0.81	0.78	-0.48	0.0	0.0	0.0	-0.05	-0.7	GLUE
HOWL	0.89		0.88	0.73	-0.53	0.0	0.0	0.0	-0.04	-0.68	HOWL
IKNA	0.81	0.88		0.57	-0.68	0.0	0.0	0.0	0.17	-0.55	IKNA
STOK	0.78	0.73	0.57		-0.38	0.0	0.0	0.0	-0.2	-0.68	STOK
ACHL	-0.48	-0.53	-0.68	-0.38		0.0	0.0	0.0	-0.46	0.39	ACHL
NLTX	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	NLTX
MGTA	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	MGTA
GRPH	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	GRPH
ALXO	-0.05	-0.04	0.17	-0.2	-0.46	0.0	0.0	0.0		0.44	ALXO
AADI	-0.7	-0.68	-0.55	-0.68	0.39	0.0	0.0	0.0	0.44		AADI
	GLUE	HOWL	IKNA	STOK	ACHL	NLTX	MGTA	GRPH	ALXO	AADI

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HOWL	+ 0.89	GLUE
IKNA	+ 0.88	HOWL
IKNA	+ 0.81	GLUE
STOK	+ 0.78	GLUE
STOK	+ 0.73	HOWL
STOK	+ 0.57	IKNA

High negative correlations

AADI	- 0.7	GLUE
AADI	- 0.68	STOK
ACHL	- 0.68	IKNA
AADI	- 0.68	HOWL
AADI	- 0.55	IKNA
ACHL	- 0.53	HOWL

Risk-Adjusted Indicators

There is a big difference between Design Stock performing well and Design Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Design Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
GLUE	4.02	(0.35)	0.00	(0.31)	0.00	0.00	8.40	(8.46)	23.57
HOWL	3.04	(0.58)	0.00	(0.27)	0.00	0.00	6.74	(7.10)	18.29
IKNA	1.69	(0.24)	0.00	(0.35)	0.00	0.00	3.87	(3.38)	16.13
STOK	3.24	(0.29)	0.00	(0.28)	0.00	0.00	7.03	(9.52)	27.59
ACHL	1.75	0.46	0.25	1.78	1.08	(3.36)	4.42	(2.86)	22.15
NLTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MGTA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GRPH	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALXO	5.44	(0.18)	0.00	0.19	0.00	0.00	15.43	(9.59)	35.80
AADI	3.74	0.51	0.10	54.00	4.57	(4.63)	6.76	(5.67)	62.23

Design Therapeutics Corporate Management

Aseem Ansari	CoFounder Advisor	Profile
Sean Jeffries	Chief Officer	Profile
Elizabeth Gordon	Senior Affairs	Profile
Mustapha Parekh	General Counsel	Profile
Joo MD	CEO Pres	Profile
MD FACC	Consulting Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC